Skip to content
Biodeal press coverage, certifications and industry awards arranged on a desk
Newsroom

Biodeal, on the record

Press coverage, certifications, recognitions and company milestones — from the Piramal Alternatives investment to new accreditations and global partnerships.

Insights & news

Perspectives from India's CDMO frontier

Expert perspectives on nasal spray drug delivery, injectable manufacturing, nutraceutical formulation, regulatory affairs and global export markets — alongside the latest Biodeal company news.

Filter
Company News

Biodeal Expands Sterile Injectable Manufacturing at Paonta Sahib

Biodeal Pharmaceuticals strengthens its sterile injectable CDMO capabilities through the acquisition of a Paonta Sahib manufacturing facility.

Sept 2026Read article
Industry Insights

INJECTABLE MANUFACTURERS IN INDIA

Looking for a reliable third-party injection manufacturer in India? Learn how Biodeal Pharmaceuticals supports pharma brands with WHO-GMP certified manufacturing, quality-focused processes, scalable production, and dependable injectable solutions.

Company News

Biodeal Pharmaceuticals Concludes ₹110 Crore Piramal Alternatives Investment with 20%+ IRR

Biodeal Pharmaceuticals successfully concludes its ₹110 crore investment partnership with Piramal Alternatives, delivering over 20% IRR and strong business growth

Pharmaceutical Manufacturing

PIONEER CDMO FOR NASAL DRUG DELIVERY IN INDIA

Explore how Biodeal Pharmaceuticals is supporting the growing nasal drug delivery market in India with advanced nasal spray manufacturing, analytical expertise, scalable production, and end-to-end CDMO solutions for pharmaceutical companies.

Industry Insights

India’s Pharma Supply Chain: Building Resilience Through Local Manufacturing

Explore how India is strengthening pharmaceutical supply chain resilience through API localization, CDMO partnerships, and diversified manufacturing.

Injectable CDMO

What is aseptic manufacturing in pharmaceuticals?

Inside the Grade A/B clean rooms, aseptic filling and controls behind reliable sterile injectable production.

Injectable CDMO

Lyophilisation in injectable manufacturing — what brands need to know

Why freeze-drying matters for stability, and what it means for your injectable development timeline.

Contract Manufacturing

How to choose a pharmaceutical CDMO in India

The credentials, capabilities and quality systems that separate a reliable CDMO partner from the rest.

Regulatory & Compliance

Health Canada approval secured

A key regulated-market clearance that extends Biodeal's reach into North America and validates our quality systems.

Media & press

Working on a story?

For press enquiries, interviews, company facts or media assets, reach our communications team — we typically respond within 48 business hours.

Media enquiry Contact & officesinfo@biodealpharma.com · +91 120-6025048